Leerink raises Genmab stock rating to outperform, PT steady at $27
Leerink Partners analyst shifted the rating for Genmab A/S (NASDAQ:GMAB) stock from Market Perform to Outperform, maintaining a price target (PT) of $27.00. The upgrade reflects a positive long-term ...
Genmab stock surges on strong profit beat
Shares of Genmab (NASDAQ:GMAB) climbed 7% following the announcement of its fourth-quarter earnings, which revealed a net ...
Why Genmab (GMAB) and Sonic Automotive (SAH) Are Advancing Today
Genmab (GMAB) and Sonic Automotive (SAH) are climbing 5% and 3%, respectively, after investment banks issued favorable notes ...
Genmab A/S (NASDAQ:GMAB) Rating Increased to Hold at BNP Paribas
BNP Paribas upgraded shares of Genmab A/S (NASDAQ:GMAB – Free Report) from a strong sell rating to a hold rating in a report issued on Tuesday morning,Zacks.com reports. GMAB has been the subject of a ...
Genmab upgraded to Outperform from Market Perform at Leerink
Leerink analyst Jonathan Chang upgraded Genmab (GMAB) to Outperform from Market Perform with a $27 price target, citing a longer-term view ...
TD Cowen Keeps Their Hold Rating on Genmab (GMAB)
In a report released today, Yaron Werber from TD Cowen maintained a Hold rating on Genmab (GMAB – Research Report). The company’s shares closed ...
Insider Monkey7d
Why Genmab A/S (GMAB) Is Among the Best Healthcare Stocks To Buy According to Analysts
Genmab A/S (NASDAQ:GMAB ... If you are looking for a deeply undervalued AI stock that is more promising than GMAB but that trades at less than 5 times its earnings, check out our report about ...
Investing2d
Genmab stock surges on strong profit beat
Investing.com -- Shares of Genmab (NASDAQ:GMAB) climbed 7% following the announcement of its fourth-quarter earnings, which revealed a net profit significantly surpassing consensus estimates.